The Defence Research and Development Organisation or DRDO, which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of COVID-19 patients, has called for Expression of Interest to transfer...
from NDTV News - Special https://ift.tt/3zcQO0W
via IFTTT
Post a Comment
Post a Comment